Exro Technologies Inc. T.EXRO

indicated

[tbear47]

Gotta agree w/Simp. If the current Exro scenario is not to your liking - simply move on. But the constant whining is grating - as in nails on a blackboard.

[ddogold]

I'm guessing that the vast majority of posters here are actual share holders , with a few obvious exceptions , and as such , what with this being a public forum , are entitled to voice their beefs with both management , the IR Department and current share price . If people are tired of reading these posts just put the members on ignore . 

[SIMPLICITI1]

ddogold,  Yes, as a public forum, people can say pretty much whatever they want, within the somewhat loosey goosey guidelines promoted by stockhouse. This would include telling people that whining is not an effective investment strategy.  I will assume that you are an intelligent enough individual to realize that placing someone on ignore removes the ability to view all of their

[Pandora]

I'll use the 'subject' line. It seems to be indicated on the USPTO site that the patent for control of battery cells is about to be issued -- i.e. a date will be given for issuance. They have not posted the 'documents' today but they have posted a 'transaction' re 'PUB' which to me suggests a publish of patent info. (I could be wrong -- we'll see what

[sorrenson]

What I am reading is this patent was granted on July 25 2023 and is "continuation of the 17/727,143" Exro Patent July 25 2023

[Pandora]

The patent you are referring to is one that I posted about back in July. It is a different Application Number and a different Publication number than the one I posted. You will notice there is a slight difference in wording in the description. One refers to "Controllable Units of Battery Cells" while the other refers to "Control of a Plurality of Battery Cells". The one I am

[sorrenson]

 One of lifes little mysteries as it does state  Related U.S. Application Data  Continuation of application No. 17/727,143, filed on Apr. 22, 2022.

[Pandora]

Yeah, I just take them as they come without trying to analyze the why.

[SIMPLICITI1]

Continuations of patents already granted is normal course for many companies that wish to create a family of patents to broaden protection and widen the moat. It is also more cost effective as it builds on claims already granted In this case they now have patents for controlling individual cells, a plurality of cells, units made up of a plurality of cells and cells within a plurality of units.

[newcoin]

This will be HUGE!